Publikation: Recovery From COVID-19-Related Olfactory Disorders and Quality of Life : Insights From an Observational Online Study
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Although olfactory disorders (OD) are among the most significant symptoms of COVID-19, recovery time from COVID-19-related OD and their consequences on the quality of life remain poorly documented. We investigated the characteristics and behavioral consequences of COVID-19-related OD using a large-scale study involving 3111 French respondents (78% women) to an online questionnaire over a period of 9 months covering different epidemic waves (from 8 April 2020 to 13 January 2021). In the patients who subjectively recovered from COVID-19-related OD (N = 609), recovery occurred on average after 16 days and most of the time within 1 month ("normal" recovery range); 49 subjectively recovered in 1-2.5 months, and several cases took up to 6.5 months. Among the patients with ongoing OD (N = 2502), 974 were outside the "normal" recovery range (persistent OD) and reported OD for 1-10 months. Developing a persistent OD was more likely with increasing age and in women and was more often associated with parosmia and phantosmia. The deleterious impact of COVID-19-related OD on the quality of life was significantly aggravated by OD duration and was more pronounced in women. Because persistent OD is not infrequent after COVID-19, has deleterious consequences on the quality of life, and receives few solutions from the health practitioners, it would be beneficial to implement screening and treatment programs to minimize the long-term behavioral consequences of COVID-19-related OD.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
FERDENZI, Camille, Christophe BOUSQUET, Pierre-Emmanuel AGUERA, Morgane DANTEC, Christelle DAUDÉ, Lesly FORNONI, Arnaud FOURNEL, Aurélien KASSAN, Marylou MANTEL, Maëlle MORANGES, 2021. Recovery From COVID-19-Related Olfactory Disorders and Quality of Life : Insights From an Observational Online Study. In: Chemical Senses. Oxford University Press (OUP). 2021, 46, bjab028. ISSN 0379-864X. eISSN 1464-3553. Available under: doi: 10.1093/chemse/bjab028BibTex
@article{Ferdenzi2021Recov-57035, year={2021}, doi={10.1093/chemse/bjab028}, title={Recovery From COVID-19-Related Olfactory Disorders and Quality of Life : Insights From an Observational Online Study}, volume={46}, issn={0379-864X}, journal={Chemical Senses}, author={Ferdenzi, Camille and Bousquet, Christophe and Aguera, Pierre-Emmanuel and Dantec, Morgane and Daudé, Christelle and Fornoni, Lesly and Fournel, Arnaud and Kassan, Aurélien and Mantel, Marylou and Moranges, Maëlle}, note={Article Number: bjab028} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/57035"> <dc:contributor>Daudé, Christelle</dc:contributor> <dc:creator>Aguera, Pierre-Emmanuel</dc:creator> <dc:creator>Fornoni, Lesly</dc:creator> <dc:rights>terms-of-use</dc:rights> <dcterms:issued>2021</dcterms:issued> <dc:creator>Ferdenzi, Camille</dc:creator> <dcterms:title>Recovery From COVID-19-Related Olfactory Disorders and Quality of Life : Insights From an Observational Online Study</dcterms:title> <dc:contributor>Ferdenzi, Camille</dc:contributor> <dc:contributor>Kassan, Aurélien</dc:contributor> <dc:contributor>Aguera, Pierre-Emmanuel</dc:contributor> <dc:creator>Mantel, Marylou</dc:creator> <dc:contributor>Moranges, Maëlle</dc:contributor> <dc:contributor>Bousquet, Christophe</dc:contributor> <dc:creator>Kassan, Aurélien</dc:creator> <dc:creator>Fournel, Arnaud</dc:creator> <dc:contributor>Fornoni, Lesly</dc:contributor> <dc:creator>Bousquet, Christophe</dc:creator> <dc:contributor>Fournel, Arnaud</dc:contributor> <dc:creator>Dantec, Morgane</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-29T09:28:13Z</dcterms:available> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/> <dc:contributor>Dantec, Morgane</dc:contributor> <dc:language>eng</dc:language> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:contributor>Mantel, Marylou</dc:contributor> <dcterms:abstract xml:lang="eng">Although olfactory disorders (OD) are among the most significant symptoms of COVID-19, recovery time from COVID-19-related OD and their consequences on the quality of life remain poorly documented. We investigated the characteristics and behavioral consequences of COVID-19-related OD using a large-scale study involving 3111 French respondents (78% women) to an online questionnaire over a period of 9 months covering different epidemic waves (from 8 April 2020 to 13 January 2021). In the patients who subjectively recovered from COVID-19-related OD (N = 609), recovery occurred on average after 16 days and most of the time within 1 month ("normal" recovery range); 49 subjectively recovered in 1-2.5 months, and several cases took up to 6.5 months. Among the patients with ongoing OD (N = 2502), 974 were outside the "normal" recovery range (persistent OD) and reported OD for 1-10 months. Developing a persistent OD was more likely with increasing age and in women and was more often associated with parosmia and phantosmia. The deleterious impact of COVID-19-related OD on the quality of life was significantly aggravated by OD duration and was more pronounced in women. Because persistent OD is not infrequent after COVID-19, has deleterious consequences on the quality of life, and receives few solutions from the health practitioners, it would be beneficial to implement screening and treatment programs to minimize the long-term behavioral consequences of COVID-19-related OD.</dcterms:abstract> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/57035"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Moranges, Maëlle</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-29T09:28:13Z</dc:date> <dc:creator>Daudé, Christelle</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/> </rdf:Description> </rdf:RDF>